United States Blood Testing Market 2025: Size Share, Trends, Latest innovations | Top Companies - Bio-Rad Laboratories Inc., Grifols, Abbott Laboratories

"Blood Testing Market size is expected to grow at high CAGR during the forecast period (2024-2031)." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/blood-testing-market?sp

United States: Recent Industry Developments

✅ In November 2025, Labcorp launched a next-generation automated blood testing platform for rapid detection of infectious diseases and biomarkers. The platform integrates AI analytics for faster and more accurate results. It strengthens Labcorp's leadership in high-throughput diagnostic services across U.S. healthcare networks.

✅ In October 2025, Quest Diagnostics introduced expanded liquid biopsy testing for oncology patients, enabling non-invasive blood testing for cancer mutations and treatment monitoring. The solution accelerates precision medicine initiatives and patient-tailored therapies. It reflects Quest's commitment to innovative diagnostic platforms.

✅ In September 2025, Siemens Healthineers deployed a fully integrated hematology and chemistry analyzer line across major U.S. hospitals, improving throughput and reducing manual handling errors. The systems support both routine and specialized blood testing workflows. It highlights Siemens' focus on advanced laboratory automation solutions.

✅ In August 2025, Bio-Rad Laboratories expanded its molecular diagnostic blood testing portfolio to include point-of-care and hospital lab solutions for infectious disease monitoring. The expansion addresses rising demand for rapid, accurate testing. It underscores Bio-Rad's strategy in next-generation diagnostic services.

Japan: Recent Industry Developments

✅ In November 2025, Sysmex Corporation launched an AI-assisted hematology testing platform for Japanese hospitals, offering high-throughput, precise blood count analysis and predictive disease analytics. The platform improves lab efficiency and patient outcomes. It reinforces Sysmex's leadership in domestic diagnostic innovation.

✅ In October 2025, Fujirebio, Inc. expanded its blood biomarker testing portfolio for oncology and cardiovascular diseases, integrating automated sample processing with enhanced sensitivity. The solution supports early detection and treatment monitoring in Japanese clinical settings. It highlights Fujirebio's commitment to advanced diagnostics.

✅ In September 2025, Shionogi & Co., Ltd. initiated clinical programs using novel blood-based biomarkers to detect antimicrobial resistance in hospital-acquired infections. The program aims to guide therapy choices and improve infection control. It underscores Japan's focus on precision blood testing for infectious diseases.

✅ In August 2025, Olympus Corporation developed enhanced blood testing devices for point-of-care and small clinics, integrating rapid analysis with minimal sample requirements. The devices improve accessibility and reduce turnaround time. It demonstrates Japan's push for portable and efficient diagnostic technologies.

Blood Testing Market: Drivers

The blood testing market is experiencing significant growth as demand for accurate, rapid, and minimally invasive diagnostic solutions rises across healthcare systems globally. Blood tests are critical for detecting and monitoring a wide range of conditions, including infections, metabolic disorders, cardiovascular diseases, and cancers. Increasing prevalence of chronic diseases, aging populations, and routine health checkups are driving the adoption of advanced diagnostic assays. The growing emphasis on preventive healthcare and early disease detection is further fueling market expansion. Additionally, technological advancements in automated analyzers, point-of-care devices, and high-throughput testing platforms are enhancing efficiency, accuracy, and turnaround time.

Innovations in molecular diagnostics, immunoassays, and next-generation sequencing are expanding the scope of blood testing to include genetic, biomarker, and personalized medicine applications. The rise of at-home testing kits and telehealth integration is improving patient accessibility and convenience. Laboratories are increasingly outsourcing testing services to specialized diagnostic providers to manage workflow, cost, and regulatory compliance. Furthermore, government initiatives promoting large-scale screening programs and public health monitoring are boosting demand. With continuous technological advancements, growing healthcare awareness, and expanding applications, the blood testing market is poised for sustained, innovation-driven growth in the coming years.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/blood-testing-market?sp

Blood Testing Market: Major Players

Bio-Rad Laboratories Inc., Grifols, Abbott Laboratories, F. Hoffmann-La Roche, Siemens Healthineers, Biomérieux, Thermo Fisher Scientific, Inc., Ortho Clinical Diagnostics, Inc., Becton, Dickinson and Company, Chembio Diagnostics, Inc. and Danaher Corporation. In the blood testing market, Bio-Rad Laboratories Inc.

Segment Covered in the Blood Testing Market:

By Product Type
The market is segmented into Instruments, Reagents & Kits, and Software and Services. The instruments segment is further classified into Outright Purchase and Rental Purchase, with outright purchase dominating due to long-term cost efficiency and reliability in diagnostic operations. Reagents & Kits include NAT Reagents & Kits, ELISA Reagents & Kits, and Other Reagents, which collectively account for a significant share driven by their recurring demand and critical role in accurate testing. Software and services are also gaining traction due to the integration of digital solutions for data management and workflow optimization.

By Test Type
Based on test type, the market is categorized into Complete Blood Count, Basic Metabolic Panel, Blood Enzyme Tests, Blood Clotting Tests, and Blood Cholesterol Tests. Among these, complete blood count (CBC) tests dominate owing to their wide diagnostic application in detecting infections, anemia, and overall health assessment.

By Technology
The market is classified into Next-Generation Sequencing (NGS), Nucleic Acid Test (NAT), Enzyme-Linked Immunosorbent Assay (ELISA), Western Blot Assay, Rapid Tests, and Others. NAT and ELISA hold major market shares due to their high sensitivity and specificity in detecting infections, while NGS is emerging as a cutting-edge technology for advanced molecular diagnostics.

By End-User
End-users include Hospitals, Blood Banks, and Others. Hospitals represent the largest share due to the high volume of patient testing and integrated diagnostic infrastructure, while blood banks significantly contribute to demand through their focus on screening and ensuring blood safety.

Research Process:

Both primary and secondary data sources have been used in the Blood Testing Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Blood Testing Market Research Industry:

➠ Who leads the Blood Testing industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Blood Testing market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Blood Testing market growth?
➠ What are the dominant sales and distribution strategies in the Blood Testing industry?

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=blood-testing-market
(Purchase 2 or more Repots and get 50% Discount)

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.